Standard / Gradual Approach (3.0 mL 3.33 mg/mL total blend) Reconstitute: Add 3.0 mL bacteriostatic water to the single 10 mg blend vial (one combined Cagrilintide + Semaglutide vial) final concentration ~3.33 mg/mL (3,333 mcg/mL of total blend)
For BPC-157, the most useful research workflow is to identify the product form, read the supplier storage language, check whether the vial is lyophilized or reconstituted, and document the storage plan before mixing
GHK-Cu Nasal Spray Questions about this Product
The following protocols represent synthesized guidance from preclinical research, clinical observations, and community experience
Route of administration: IM, IV or SC as directed by veterinarian
More recent Phase 3 data from the REDEFINE 1 trial showed Cagrilintide monotherapy producing 11.8% weight loss over 68 weeks